ORG 32489 RECOMBINANT FSH

CHOLINERGIC CHANNEL ACTIVATOR-TRANSDERMAL DELIVERY SYSTEM

HYALURONIC ACID LMW

NITROGLYCERIN

BULK CRUDE PROPOFOL

TRIETHYL 3-BROMOPROPANE-1, 1, 1-TRICARBOXYLATE

SHOLEX 6002B AND SHO-ALLOMER MA 411 AND MA 422

CHLOROFLUOROCARBON 11, 12, AND 114.

D-(-)-PHENYGLYCINE DANE SALT

3,6-Dimethoxy-2-nitrobenzenecarbaldehyde

C9H9NO5

Strontium titanium oxide, 99+% (metals basis)

O3SrTi

METHIMAZOLE USP

ATRACURIUM BESYLATE USP

Tetrazolo[1,5-a]pyridine-7-carboxylic acid

C6H4N4O2

Cupric hexafluorosilicate

CuF6Si

HY-50 HYALURONATE SODIUM STERILE INJECTION

2200 PPM NITRIC OXIDE/BALANCE NITROGEN GAS MIXTURE

KANE ACE B-22, B-52, B-56, AND B-522

KANE ACE B-22, B-52, B-56, AND B-522

Etrasimod Arginine

C32H40F3N5O5

KANE ACE B-22, B-52, B-56, AND B-522

STERILE WATER FOR INJECTION

DERMAZ 88 (AZELAIC ACID)

MPE953M-3

STAMYLAN LD 2304A

CYCLOSPORINE MANFACTURED IN BASLE, SWITZERLAND.

2-ISOPROPYL-4-(N-METHYL) AMNINOMETHYLTHIAZOLE

CRL-1005 (POE-POP-POE BLOCK COPOLYMER 120.5)

METHOD MS23.1, GC/MS ANALYSIS OF ENALAPRIL AND ENALAPRILAT IN HUMAN URINE

METHOD MS23 REVISION 1 GC/MS ANALYSIS OF ENALAPRIL AND ENALAPRILAT IN HUMAN PLASMA

ARTIFICIAL COOLING COMPOUND #6883

PRAZIQUANTEL